Isolation and characterization of phage display-derived scFv antibodies against human parechovirus 1 VP0 protein

Eero Hietanen1, Lav Tripathi1, Eeva-Christine Brockmann2

  • 1Institute of Biomedicine, University of Turku, Turku, Finland.

Scientific Reports
|August 4, 2022
PubMed

Insights

Researchers developed novel phage display antibodies for detecting human parechoviruses (PeVs), common causes of various illnesses. These new antibodies show promise for advancing diagnostic tools for PeV infections.

Area of Science:

  • Virology
  • Immunology
  • Biotechnology

Background:

  • Human parechoviruses (PeVs) cause a spectrum of diseases, from mild symptoms to severe neurological infections.
  • Currently, no specific antibodies exist for visualizing PeV infections, hindering diagnosis and research.

Purpose of the Study:

  • To isolate and characterize novel single chain variable fragment (scFv) antibodies against human parechoviruses using phage display.
  • To evaluate the diagnostic potential of these antibodies against various PeV types.

Main Methods:

  • Phage display panning was employed using recombinant PeV-A1-VP0 protein as the target.
  • Enzyme-linked immunosorbent assay (ELISA), Western blot, and immunofluorescence microscopy (IFA) were used to validate antibody binding.
  • Peptide library generation and sequencing were performed to identify antibody epitopes.

Main Results:

  • Three scFv clones (scFv-55, -59, -71) were successfully isolated and showed positive ELISA results against PeV-A1 VP0.
  • ScFv-55 and -71 demonstrated broad reactivity against PeV-A1 isolates and recognized PeV types 1-6 in IFA and ELISA.
  • A conserved epitope (VVTYDSKL) was identified, present in numerous PeV sequences, particularly PeV-A1.

Conclusions:

  • The study reports the first isolation of broad-range phage display antibodies against human parechoviruses.
  • These antibodies hold significant potential for the development of new diagnostic tools for PeV infections.

Related Concept Videos